tolvaptan has been researched along with Heart Valve Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, L; Liu, H; Ma, L; Wu, Z; Xu, L; Yuan, F; Zhai, Z; Zhang, J; Zhou, J | 1 |
| Fukada, Y; Hirota, M; Hoshino, J; Isomura, T; Kondo, T; Takahashi, Y | 1 |
| Fukushima, S; Kawamura, M; Kuratani, T; Miyagawa, S; Nishi, H; Saito, T; Sawa, Y; Toda, K; Ueno, T; Yoshikawa, Y; Yoshioka, D | 1 |
3 other study(ies) available for tolvaptan and Heart Valve Diseases
| Article | Year |
|---|---|
Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Diuretics; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Tolvaptan; Torsemide; Treatment Outcome; Tricuspid Valve; Tricuspid Valve Insufficiency; Water-Electrolyte Balance | 2019 |
[Effectiveness of tolvaptan for postoperative heart failure in a patient with combined valvular disease and pulmonary hypertension].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Male; Middle Aged; Postoperative Complications; Tolvaptan | 2014 |
Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiopulmonary Bypass; Clinical Trials as Topic; Diuretics; Edema, Cardiac; Female; Heart Valve Diseases; Heart Valves; Hemodynamics; Humans; Male; Middle Aged; Postoperative Care; Postoperative Complications; Prospective Studies; Receptors, Vasopressin; Tolvaptan; Treatment Outcome | 2015 |